Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Overview of attention for article published in New England Journal of Medicine, November 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 76 news outlets
blogs: 7 blogs
policy: 3 policy sources
twitter: 445 X users
patent: 15 patents
facebook: 18 Facebook pages
wikipedia: 4 Wikipedia pages

googleplus: 2 Google+ users
reddit: 11 Redditors
f1000: 1 research highlight platform
video: 3 YouTube creators
guideline: 26 clinical guideline sources
podcasts: 5 podcasts

Readers on

mendeley: 1876 Mendeley

So far, Altmetric has seen 3 YouTube videos from 3 creators.

Biohacking Update: 10 Breakthroughs You Can't Afford to Miss

User BioHackers Longevity on YouTube, 10 Jun 2026

New aging acceleration research shows biological markers spike at ages 44 and 60. Understand these critical milestones to…

Nov 14 2025 This Week in Cardiology

User Medscape on YouTube, 14 Nov 2025

Listener feedback on the PISCES trial, AHA news (including a big PCSK9i trial), beta-blockers post MI, LAAC, and post-AF…

Café com Journal - Os 10 Trials que Marcaram a Cardiologia em 2018

User CardioLearning on YouTube, 08 Jan 2019

O primeiro Café com Journal de 2019 traz uma retrospectiva dos 10 trials que marcaram o ano de 2018! Os artigos cuidadosamente…

This page shows the most recent videos that mention this research output. Click here to find out how to access more activity.